FDA Inspection 788580 — Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
The FDA completed an inspection of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC on June 20, 2012 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 20, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Andover, MA (United States)